Local Institution - Seattle
415 1st Avenue North
Seattle, Washington 98109

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Oncology Clinical Trial
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) or in Combination With Nivolumab and Anti-CTLA4 Antibody (Ipilimumab) in Patients With Select Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution - Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials